[1. Fox KAA, Metra M, Morais J, Atar D. The myth of ‘stable’ coronary artery disease. Nat Rev Cardiol. 2020;17:9-21. Epub 2019 Jul 29.10.1038/s41569-019-0233-y]Search in Google Scholar
[2. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407-477.10.1093/eurheartj/ehz425]Search in Google Scholar
[3. Sorbets E, Fox K, Elbez Y, et al. Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry. Eur Heart J. 2019;00:1-10.]Search in Google Scholar
[4. Daly CA, De Stavola B, Sendon JL, et al. Predicting prognosis in stable angina—results from the Euro heart survey of stable angina: prospective observational study. BMJ. 2006;332:262-267.10.1136/bmj.38695.605440.AE]Search in Google Scholar
[5. Juarez-Orozco LE, Saraste A, Capodanno D, et al. Impact of a decreasing pre-test probability on the performance of diagnostic tests for coronary artery disease. Eur Heart J Cardiovasc Imaging. 2019; 20:1198-1207.10.1093/ehjci/jez054]Search in Google Scholar
[6. Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949-3003.10.1093/eurheartj/eht296]Search in Google Scholar
[7. SCOT-HEART investigators. CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel group, multicentre trial. Lancet. 2015;385:2383-2391.10.1016/S0140-6736(15)60291-4]Search in Google Scholar
[8. Knuuti J, Ballo H, Juarez-Orozco LE, et al. The performance of noninvasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability. Eur Heart J. 2018;39:3322-3330.10.1093/eurheartj/ehy26729850808]Search in Google Scholar
[9. Piepoli MF, Hoes AW, Agewall S, et al. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention ---amp--- Rehabilitation (EACPR). Eur Heart J. 2016;37:2315-2381.10.1093/eurheartj/ehw106498603027222591]Search in Google Scholar
[10. Booth JN III, Levitan EB, Brown TM, Farkouh ME, Safford MM, Muntner P. Effect of sustaining lifestyle modifications (nonsmoking, weight reduction, physical activity, and mediterranean diet) after healing of myocardial infarction, percutaneous intervention, or coronary bypass (from the REasons for Geographic and Racial Differences in Stroke Study). Am J Cardiol. 2014;113:1933-1940.10.1016/j.amjcard.2014.03.033434857624793668]Search in Google Scholar
[11. Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013;34:2940-2948.10.1093/eurheartj/eht29523907142]Search in Google Scholar
[12. Ferrari R, Pavasini R, Camici PG, et al. Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment. Eur Heart J. 2019;40:190-194.10.1093/eurheartj/ehy504]Search in Google Scholar
[13. Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39:213-260.10.1093/eurheartj/ehx419]Search in Google Scholar
[14. Orme RC, Parker WAE, Thomas MR, et al. Study of two dose regimens of ticagrelor compared with clopidogrel in patients undergoing percutaneous coronary intervention for stable coronary artery disease (STEEL-PCI). Circulation. 2018;138:1290-1300.10.1161/CIRCULATIONAHA.118.034790]Search in Google Scholar
[15. Eikelboom JW, Connolly SJ, Bosch J, et al. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med. 2017;377:1319-1330.10.1056/NEJMoa1709118]Search in Google Scholar
[16. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40:87-165.10.1093/eurheartj/ehy394]Search in Google Scholar
[17. Xaplanteris P, Fournier S, Pijls NHJ, et al. Five-year outcomes with PCI guided by fractional flow reserve. N Engl J Med. 2018;379:250-259.10.1056/NEJMoa1803538]Search in Google Scholar
[18. Velazquez EJ, Lee KL, Jones RH, et al. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med. 2016;374:1511-1520.10.1056/NEJMoa1602001]Search in Google Scholar
[19. Windecker S, Stortecky S, Stefanini GG, et al. Revascularisation versus medical treatment in patients with stable coronary artery disease: Network meta-analysis. BMJ. 2014;348:g3859.10.1136/bmj.g3859]Search in Google Scholar
[20. Al-Lamee R, Thompson D, Dehbi HM, et al. Percutaneous coronary intervention in stable angina (ORBITA): a doubleblind, randomised controlled trial. Lancet. 2018;391:31-40.10.1016/S0140-6736(17)32714-9]Search in Google Scholar
[21. Stergiopoulos K, Brown DL. Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials. Arch Intern Med. 2012;172:312-319.10.1001/archinternmed.2011.148422371919]Search in Google Scholar
[22. Bangalore S, Pursnani S, Kumar S, Bagos PG. Percutaneous coronary intervention versus optimal medical therapy for prevention of spontaneous myocardial infarction in subjects with stable ischemic heart disease. Circulation. 2013;127:769-781.10.1161/CIRCULATIONAHA.112.13196123325526]Search in Google Scholar
[23. International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA). https://professional.heart.org/professional/ScienceNews/UCM_505226_ISCHEMIA-Clinical-Trial-Details.jsp (06 December 2019)]Search in Google Scholar